Antithrombotic effect of enalapril, an angiotensin-converting enzyme inhibitor, on venous thrombosis in rats

Polish Journal of Pharmacology

Volumn 48, Issue 1, 1996, Pages 117-120

  Pawlak, Robert ^a   Chabielska, Ewa ^a   Buczko, Włodzimierz ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

captopril; enalapril; rat; renin angiotensin system; venous thrombosis

Indexed keywords

ANTICOAGULANT AGENT; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; INCIDENCE; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; THROMBOCYTE AGGREGATION; VEIN THROMBOSIS;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTIFIBRINOLYTIC AGENTS; BLEEDING TIME; BLOOD PRESSURE; CAPTOPRIL; ENALAPRIL; MALE; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; RATS; THROMBOLYTIC THERAPY; THROMBOPHLEBITIS;

EID: 0029882394     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (14)

1. Bagchi D., Prasad R., Das D. K.: Direct scavenging of free radicals by captopril, an angiotensin converting enzyme inhibitor. Biochem. Biophys. Res. Commun., 1989, 158, 52-57.
2. Born G. V. R., Cross M. J.: The aggregation of blood platelets. J. Physiol., 1963, 168, 178-195.
3. Chabielska E., Iacoviello L., Buczko W., Donati M. B.: Effects of some angiotensin converting enzyme inhibitors on arterial thrombosis in rat. Pol. J. Pharmacol., 1994, 46, 334-335.
4. Dejana E., Villa S., De Gaetano G.: Bleeding time in rats: A comparison of different experimental conditions. Thromb. Haemostas., 1982, 48, 108-111.
5. Goldschmidt J. E., Tallarida R. J.: Pharmacological evidence that captopril possesses endothelium-mediated component of vasodilation: effect of sulfhydryl groups on endothelium-derived relaxing factor. J. Pharmacol. Exp. Ther., 1991, 257, 1136-1145.
6. Gryglewski R. J., Palmer R. M. J., Moncada S.: Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature, 1986, 320, 454-456.
7. Harding P., Stonier C., Aber G. M.: Effect of angiotensin-converting enzyme inhibitors on glomerular eikosanoid production in normotensive and spontaneously hypertensive rats. Clinical Science, 1991, 81, 491-497.
8. Herbert J. M., Bernat A., Maffrend J. P.: Importance of platelets in experimental venous thrombosis in the rat. Blood, 1992, 80, 2281-2286.
9. Ikeda K., Nara Y., Yamori Y.: Indirect systolic and mean blood pressure determination by a new tail cuff method in spontaneously hypertensive rats. Lab. Animals, 1991, 25, 26-29.
10. Malinowska B., Chabielska E., Pietraszek M., Buczko W.: The serotonergic mechanisms are not involved in the inhibitory effect of captopril on rat platelet aggregation. Haemostasis, 1990, 20, 48-53.
11. Pfeffer M. A., Brunwald E., Moye L., (SAVE Investigators): Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. New Engl. J. Med., 1992, 327, 670-677.
12. Radomski M. W., Moncada S.: Regulation of platelet function by nitric oxide. Thromb. Haemorrh. Disorders, 1993, 7/1, 1-7.
13. Reyers I., De Gaetano G., Donati M. B.: Venostasis-induced thrombosis in rat is not influenced by circulating platelet or leukocyte number. Agents Actions, 1989, 28, 137-140.
14. Steward G. J., Ritchie W. G. M., Lynch P. R.: Venous endothelial damage produced by massive sticking and emigration of leukocytes. Am. J. Pathol., 1974, 74, 507-511.